Laparoscopic-guided TAP Block in Patients Undergoing Gastric Bypass

• Status: Unknown status
• Trial end date: 2017-09-01
• Target enrollment: 0
• Participant gender: All

Summary

A prospective randomized trial will be performed. Patients undergoing gastric bypass will be randomized into 2 groups: patients undergoing laparoscopic-guided transversus abdominis plane (TAP) block as part of multimodal analgesia (Group 1), associated with postoperative intravenous analgesia, and patients receiving only postoperative intravenous analgesia (Group 2).

Postoperative pain will be assessed with a Visual Analogic Scale 24h after surgery and morphine needs will be quantified.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital General Universitario Elche
• Treatments: Dipyrone

Criteria

Inclusion Criteria:

• Body mass index (BMI) >40 Kg/m2

• BMI >35 Kg/m2 and obesity associated comorbidities

• Patients undergoing laparoscopic Roux en Y gastric bypass

Exclusion Criteria:

• Patients undergoing other bariatric procedures, different than Roux en Y gastric bypass

• Patients undergoing open bariatric surgery